Dr Aniss G. E. Chami, Chief Executive Officer and Co-founder of Vitex Pharmaceuticals is widely regarded as an industry leader with unrivalled experience and qualifications. Under Dr Chami’s leadership, Vitex has been cemented as a leading Australian manufacturer of high quality complementary medicines.
Dr Chami graduated from Macquarie University completing his Bachelor of Medical Science with Honours (B Med Sci) (Hon). He went on to complete his Master of Pharmacy (MPharm) at the University of Sydney, before completing his Bachelor of Medicine and Bachelor of Surgery (MBBS) at the prestigious Sydney School of Medicine, University of Notre Dame. Dr Chami also holds a Master’s Degree in Financial Management (MFM) and a Master’s Degree in Business Administration (MBA) at the world-ranking Macquarie Graduate School of Management.
With a remarkable list of credentials, Dr Chami is also one of the youngest CEOs in the industry. Unequivocally, however, he is considered as one of the most experienced - having been immersed in the industry at an early age under the tutelage of his father, Vitex Chairman, Elie Chami. He was named Manufacturing Executive of the Year in 2017 and 2018 by CEO Magazine and received the 2019 Corporate Citizen of the Year Award by Blacktown City Council. Dr Chami is currently serving as a Board Director of Consumer Health Products (CHP) Australia, the peak body representing the manufacturers and distributors of consumer healthcare products.
Dr Chami is also a former Board member of the Complementary Medicines Association of Australia (CMA), and the Chair of the Good Manufacturing Practice (GMP) Manufacturing and Quality Committee.
Having established one of the few Australian-owned manufacturing organisations in complementary medicine, Dr Chami is passionate about Australian-made product. He has created a culture and international reputation for innovative quality systems underscored by an entrepreneurial spirit. Above all, he has shown that profitability and integrity can go hand in hand.
In 2018, Dr Chami signed an agreement with the NSW Government for a state-of-the-art pharmaceutical training and research institute at the Western Sydney Aerotropolis. The Institute will be the first in Australia to offer dedicated training in pharmaceutics and pharmaceutical process engineering.